Rimifon and Cellcept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rimifon (isoniazid) and Cellcept (mycophenolate mofetil). Common drug interactions include hepatocellular injury among females and hypomagnesaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Rimifon and Cellcept. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Rimifon?

Rimifon has active ingredients of isoniazid. eHealthMe is studying from 925 Rimifon users. Check the latest studies of Rimifon.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

On Jul, 14, 2026

55 people who take Rimifon and Cellcept together, and have interactions are studied.

What are the common drug interactions of Rimifon and Cellcept, by gender? *:

female:

Hepatocellular injury (liver injury)
Drug level increased
Mixed liver injury
Tuberculosis (a bacterial infection by mycobacterium tuberculosis)
Abdominal discomfort
Anaemia (lack of blood)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Colitis ulcerative (inflammation of colon with ulcer)
Dehydration (dryness resulting from the removal of water)
Drug toxicity

male:

Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
Overdose
Transplant rejection (a transplant material is not worked)
Agitation (state of anxiety or nervous excitement)
Anxiety
Arthralgia (joint pain)
Blindness
Blood amylase increased
Blood creatinine increased

What are the common drug interactions of Rimifon and Cellcept, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Drug level increased
Cytomegalovirus infection
Neutropenia (an abnormally low number of neutrophils)
Hepatocellular injury (liver injury)
Renal failure (kidney dysfunction)

20-29:

n/a

30-39:

Mixed liver injury

40-49:

Hepatocellular injury (liver injury)
Agitation (state of anxiety or nervous excitement)
Anxiety
Blood amylase increased
Blood creatinine increased
Creatinine renal clearance decreased
Delirium (wild excitement)
Depression
Encephalitis (inflammation of the brain)
Immunosuppressant drug level decreased

50-59:

Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
Leukopenia (less number of white blood cells in blood)
Renal failure (kidney dysfunction)
Thrombocytopenia (decrease of platelets in blood)
Type 2 diabetes mellitus
Weight decreased

60+:

Hyperuricaemia (level of uric acid in the blood that is abnormally high)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Blindness
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Colitis ulcerative (inflammation of colon with ulcer)
Cytolytic hepatitis (dissolution or destruction of a liver cell)
Dehydration (dryness resulting from the removal of water)
Depression
Drug toxicity

What are the existing conditions these people have? *

Pyogenic Liver Abscess (liver abscess caused by bacteria): 16 people, 29.09%
Latent Tuberculosis (hidden tuberculosis): 16 people, 29.09%
High Blood Pressure: 13 people, 23.64%
High Blood Cholesterol: 8 people, 14.55%
Pain: 7 people, 12.73%
Neuralgia (pain in one or more nerves): 7 people, 12.73%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 5 people, 9.09%
Lymph Node Tuberculosis: 4 people, 7.27%

* Approximation only. Some reports may have incomplete information.

Do you take Rimifon and Cellcept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously